NCADD Logo
Contact Us | E-Newsletter Subscribe | Affiliate Login/Logout

Donate Now

  • About NCADD
  • Programs and Services
  • Affiliate Network
  • NCADD Bookstore
  • For the Media
  • Get Help
    • Overview
    • Local Resources
    • Family Education
    • Intervention
    • Mutual Aid / Support
    • Medication & Recovery
    • Recovery Stories
    • Addiction Medicine
    Get Help Congratulations - You are on the way -The start of the process begins here and now. Learn More....
  • Learn About Alcohol
    • Overview
    • FAQ's / Facts
    • Signs and Symptoms
    • Alcohol and Crime
    • Drinking and Driving
    • Fetal Alcohol Effects
    • Seniors, Vets and Women
    • Workplace
    Learn About Alcohol Curious about what drinking will do to you? Is there a serious problem for me or a loved one? What to do? Learn More....
  • Learn About Drugs
    • Overview
    • FAQ's/Facts
    • Marijuana
    • Prescription Drugs
    • Drugged Driving
    • Drugs and Crime
    • Signs and Symptoms
    • Seniors, Vets and Women
    Learn About Drugs A source of information about substances that alter the mental and emotional state. Learn More....
  • For Parents
    • Overview
    • FAQ's/Facts
    • Talking With Children
    • Stories From Parents
    • Prevention Tips
    • What to Look For
    • Family History
    • Help for Parents
    For Parents Worried about the kids? What to do for them and for us. You can be the key to their early recovery. Learn More....
  • For Youth
    • Overview
    • FAQ's/Facts
    • Underage and College
    • Drugs and Crime
    • Alcohol Energy Drinks
    • Concerned for Someone
    • Prevention Tips
    • Recovery Stories
    For Youth Think you may have a problem with your drinking or drug use? Concerned about a parent or friend? Learn More....
  • For People In Recovery
    • Overview
    • Local Resources
    • Celebrate Recovery
    • ROAR
    • Recovery: Definition
    • Advocacy & Anonymity
    • Mutual Aid/ Support
    • Recovery Events
    For People In Recovery Recovery from alcoholism and drug addiction is happening every day for millions of people. Learn More....
  • For Family & Friends
    • Overview
    • FAQ's/Facts
    • Signs and Symptoms
    • Helping Someone
    • Family Education
    • Intervention
    • Family Disease/ Recovery
    • Recovery Stories
    For Family & Friends The disease of alcoholism and drug addiction affects the whole family . Has your life been affected? Learn More....
Home : In the News : FDA Panel Votes to Toughen Restrictions on Hydrocodone Combination Drugs

FDA Panel Votes to Toughen Restrictions on Hydrocodone Combination Drugs

PDF | Print | E-mail
Tweet
Share

Rx in handA Food and Drug Administration (FDA) advisory panel voted Friday to strengthen restrictions on hydrocodone combination drugs, such as Vicodin.

The panel recommended that the FDA make the drugs more difficult to prescribe.

Supporters of the panel's recommendation say it could help reduce addiction to painkillers, The New York Times reports. The agency is likely to adopt the panel's proposal, the article notes.

The panel made the recommendation in a 19-to-10 vote. Opponents were skeptical the proposal would be effective against prescription drug abuse. They also were concerned the changes would make it more difficult for patients in chronic pain to obtain relief. At the two-day FDA hearing about the proposal, opponents noted it would require frail nursing home residents to make a trip to the doctor's office to obtain pain prescriptions.

The proposal forbids refills without a new prescription, as well as faxed prescriptions and those called in by phone. Distributors of the drugs would have to store the drugs in special vaults. Nurse practitioners and physician assistants would be banned from prescribing the drugs.

Some panelists said the proposal could have the unintended effect of increasing abuse of other drugs, such as heroin.

"Many of us are concerned that the more stringent controls will eventually lead to different problems, which may be worse," said Dr. John Mendelson, a senior scientist at the Addiction and Pharmacology Research Laboratory at the California Pacific Medical Center Research Institute in San Francisco.

The FDA convened the panel at the request of the Drug Enforcement Administration. If the FDA accepts the panel's recommendation, it will be sent to the Department of Health and Human Services, which will make the final decision.

Taking prescription drugs not prescribed for you by a doctor or in a way that hasn't been recommended by a doctor, can be more dangerous than you think. In fact, it can be fatal.

Prescription drugs are the third most commonly abused category of drugs, behind alcohol and marijuana and ahead of cocaine, heroin, and methamphetamine. Click here to read more.

For the Media
  • Overview
  • Press Kit
  • In The News
  • Press Releases & News Articles
  • Alcohol & Drug Information
  • Glossary of Terms
  • NCADD Awareness Month Programs
  • Key Staff Bios
  • Annual Reports and 990s
Featured Video

NCADD Self Tests

Am I Alcoholic?

  • TAKE THIS QUIZ

Am I Drug Addicted?

  • TAKE THIS QUIZ

Self Test for Teens

  • TAKE THIS QUIZ
In the News
  • Study Links Military Deployment with Child Alcohol, Drug Problems
  • Almost One in Five High School Age Boys in U.S. Have Received ADHD Diagnosis
  • Drug-Related Deaths Continue to Increase in the United States
  • Study Tests Safety of Drug Treatment for Meth Addiction
  • April Marks 27th Alcohol Awareness Month
Most Popular
  • 2.5 Million Alcohol-Related Deaths Worldwide- Annually
  • Alcohol, Drugs and Crime
  • April is NCADD Alcohol Awareness Month
  • Alcohol and Drug Abuse Affects Everyone in the Family
  • Registry of Addiction Recovery
Connect with NCADD
  • Facebook: NCADDNational
  • Twitter: NCADDNational
  • YouTube: NCADDNational

National Council on Alcoholism and Drug Dependence, Inc.

217 Broadway, Suite 712 , New York, NY 10007 | Phone: 212-269-7797 | Fax 212-269-7510

email: national@ncadd.org  http://www.ncadd.org

HOPE LINE: 800 NCACALL (24 hour Affiliate referral)

Privacy Notice | Terms of Use | Return Policy | Contact Us | Site Map